Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67
The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study
Jimmie L. Pirtle, Melissa D. Hickman, Varun C. Boinpelly, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 52-59
Open Access | Times Cited: 39
The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders
Gregory T. Collins, Lisa R. Gerak, Charles P. France
Neuropharmacology (2017) Vol. 142, pp. 63-71
Open Access | Times Cited: 36
Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
E. Andrew Townsend, S. Stevens Negus, Justin L. Poklis, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107848-107848
Open Access | Times Cited: 30
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
Laura Brandt, Jermaine D. Jones, Suky Martinez, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107859-107859
Open Access | Times Cited: 29
Time to choose: impact of intertrial interval on selecting between methamphetamine and food reinforcement in male and female rats
Marlaina R. Stocco, Mari Purpura, Philip A. Vieira, et al.
Psychopharmacology (2025)
Open Access
Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys
Stephen J. Kohut, Jack Bergman
European Journal of Pharmacology (2018) Vol. 840, pp. 28-32
Open Access | Times Cited: 31
Role of impulsivity and reward in the anti-obesity actions of 5-HT2Creceptor agonists
Guy A. Higgins, Fiona D. Zeeb, Paul Fletcher
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1403-1418
Closed Access | Times Cited: 30
Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.
Lisa R. Gerak, Gregory T. Collins, David R. Maguire, et al.
Experimental and Clinical Psychopharmacology (2018) Vol. 27, Iss. 1, pp. 78-86
Open Access | Times Cited: 28
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration
Noelle C. Anastasio, Dennis J. Sholler, Robert G. Fox, et al.
Neuropharmacology (2020) Vol. 168, pp. 108009-108009
Open Access | Times Cited: 25
Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
Gregory T. Collins, Charles P. France
Experimental and Clinical Psychopharmacology (2018) Vol. 26, Iss. 5, pp. 488-496
Open Access | Times Cited: 24
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Converging vulnerability factors for compulsive food and drug use
Katherine M. Serafine, Laura E. O’Dell, Eric P. Zorrilla
Neuropharmacology (2021) Vol. 196, pp. 108556-108556
Open Access | Times Cited: 19
Confronting the challenge of failed translation in medications development for substance use disorders
S. Stevens Negus, Matthew L. Banks
Pharmacology Biochemistry and Behavior (2021) Vol. 210, pp. 173264-173264
Open Access | Times Cited: 18
Medications Development for Treatment of Opioid Use Disorder
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 1, pp. a039263-a039263
Open Access | Times Cited: 20
Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial
Sade E. Johns, Lori Keyser‐Marcus, Antonio Abbate, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
Frank N. Perkins, Kevin B. Freeman
Pharmacology Biochemistry and Behavior (2017) Vol. 164, pp. 40-49
Open Access | Times Cited: 16
Improving Translational Research Outcomes for Opioid Use Disorder Treatments
Jermaine D. Jones, Neil B. Varshneya, Thomas J. Hudzik, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 1, pp. 109-121
Open Access | Times Cited: 11
Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders
Maleesha Ubhayarathna, Christopher J. Langmead, Natalie Diepenhorst, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 22, pp. 4414-4429
Open Access | Times Cited: 4
Effects of long-term high-fat food or methamphetamine intake and serotonin 2C receptors on reversal learning in female rhesus macaques
Maylen Perez Diaz, Mark E. Wilson, Leonard L. Howell
Neuropsychopharmacology (2018) Vol. 44, Iss. 3, pp. 478-486
Open Access | Times Cited: 12
Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence
Valerie L. Darcey, Katherine M. Serafine
Current Pharmaceutical Design (2020) Vol. 26, Iss. 20, pp. 2385-2401
Closed Access | Times Cited: 9
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
David R. Maguire
Pharmacology Biochemistry and Behavior (2023) Vol. 234, pp. 173673-173673
Open Access | Times Cited: 3
Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeys
Melis Odabas-Geldiay, Hannah Shields, Laís F. Berro, et al.
Drug and Alcohol Dependence (2018) Vol. 194, pp. 252-256
Open Access | Times Cited: 8
The synthetic cathinone psychostimulant α‐PPP antagonizes serotonin 5‐HT2A receptors: In vitro and in vivo evidence
Yiming Chen, Bruce E. Blough, Kevin S. Murnane, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 7, pp. 990-998
Open Access | Times Cited: 7
Serotonin transporter protein in autopsied brain of chronic users of cocaine
Junchao Tong, Jeffrey H. Meyer, Isabelle Boileau, et al.
Psychopharmacology (2020) Vol. 237, Iss. 9, pp. 2661-2671
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top